lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
245 rows where filing_period = "fourth_quarter", filing_year = 2016 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1907130 | FROST BROWN TODD LLC dc15852f-9db1-4831-ba3a-9a38444e844c | 4T | FROST BROWN TODD LLC | 283572 | APPRISS | 2016 | fourth_quarter | PHA | Issues relating to prescription drug monitoring programs (PDMPs): criminal justice/health care policy/appropriations. | HOUSE OF REPRESENTATIVES | 20000 | 0 | 1 | 2016-11-29T14:02:48.887000-05:00 | |
| 1908444 | VAN SCOYOC ASSOCIATES fe6b4522-ee85-4afe-9622-48943f40bf74 | 4T | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF CONNECTICUT | 2016 | fourth_quarter | PHA | No lobbying activity. | Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 1 | 2016-12-30T20:03:34.880000-05:00 | |
| 1908457 | VAN SCOYOC ASSOCIATES c279995d-6e1d-4f60-ace4-92ef29134dc6 | Q4 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF MARYLAND BALTIMORE | 2016 | fourth_quarter | PHA | Public Law 114-92, National Defense Authorization Act for Fiscal Year 2016, Defensewide RDT&E and Defense Health Program; and Medication Therapy Management. Monitor the following: H.R.4190, To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services, Provider status. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2016-12-30T20:07:36.270000-05:00 | |
| 1908460 | VAN SCOYOC ASSOCIATES 4c083b26-49a3-4b94-834c-9478fdf2ab4d | 4T | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE | 2016 | fourth_quarter | PHA | No lobbying activity. | HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE | 50000 | 0 | 1 | 2016-12-30T20:10:37.693000-05:00 | |
| 1909103 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 37abaca1-2cdb-41b4-8bdb-137f16c33d0c | Q4 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 401103437 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 2016 | fourth_quarter | PHA | November 3, 2016 Meeting of the Pharmacy Compounding Advisory Committee Advisory Committee Meeting (topical compounds) | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE | 0 | 0 | 2017-01-05T11:21:42-05:00 | ||
| 1909141 | MR. BRIAN KELLY d7ec68e9-a9a8-4d48-b723-ccd2b886eb37 | Q4 | MR. BRIAN KELLY | 40024191 | LUNDBECK PHARMACEUTICALS | 2016 | fourth_quarter | PHA | FDA Reform | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2017-01-05T11:56:58-05:00 | |
| 1909160 | NELSON MULLINS RILEY & SCARBOROUGH f9fbbf42-3f15-4e80-9256-e210eae5db28 | Q4 | NELSON MULLINS RILEY & SCARBOROUGH | 285871 | CASCADE HEMOPHILIA CONSORTIUM | 2016 | fourth_quarter | PHA | Issues related to 340B Drug Pricing Progam | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-01-05T12:08:54-05:00 | |
| 1909163 | NELSON MULLINS RILEY & SCARBOROUGH 766b008b-3be5-4d2c-afa5-635860dbf732 | Q4 | NELSON MULLINS RILEY & SCARBOROUGH | 285871 | HEMOPHILIA OF GEORGIA | 2016 | fourth_quarter | PHA | Issues related to implementation of the ACA, Hemophilia research and treatments, and the 340B Drug Pricing Program | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-01-05T12:10:30-05:00 | |
| 1909366 | CARD & ASSOCIATES, LLC 4b45ea96-8d85-4c16-b39b-e6af76b1809e | Q4 | CARD & ASSOCIATES, LLC | 84217 | AMAZON.COM (FRA PILLPACK AN AMAZON COMPANY) | 2016 | fourth_quarter | PHA | Educate Members on pharmacy contracting with pharmacy benefit managers | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2017-01-05T17:11:49-05:00 | |
| 1909369 | CARD & ASSOCIATES, LLC ec4ffcfb-acfd-4b6b-8748-c4f8afc9a328 | 4T | CARD & ASSOCIATES, LLC | 84217 | ALLIANCE HEALTH NETWORKS, LLC | 2016 | fourth_quarter | PHA | Educate Members on pharmacy contracting with pharmacy benefit managers | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 1 | 2017-01-05T17:17:19-05:00 | |
| 1909371 | CARD & ASSOCIATES, LLC 57843b37-4b66-4f73-a246-1ca00c6ba7e6 | 4T | CARD & ASSOCIATES, LLC | 84217 | AMERICANS FOR PRESCRIPTION DRUG FAIRNESS | 2016 | fourth_quarter | PHA | Advocate for protection of 340B drug pricing program and support 340B program integrity and compliance by covered entities and pharmacies | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 1 | 2017-01-05T17:19:23-05:00 | |
| 1909982 | COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 9ec8f2a7-d9da-4c9d-b634-9a36ee4427f1 | Q4 | COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE | 11003 | COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE | 2016 | fourth_quarter | PHA | ICYMI: CAGW Releases Report on Pharmaceutical Price Controls ICYMI: CAGW Releases Report on Pharmaceutical Price Controls | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-09T11:33:39-05:00 | |
| 1910026 | KATE MOSS 584cc3b4-36bc-49f6-95b3-6250f8f5fd12 | Q4 | KATE MOSS | 25988 | CVS HEALTH | 2016 | fourth_quarter | PHA | Issues related to prescription drug abuse and drug supply chain safety. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2017-01-09T12:22:18-05:00 | |
| 1910142 | PRINTING INDUSTRIES OF AMERICA, INC. a7f507be-9e3e-4613-ab43-aa87b7d4c210 | Q4 | PRINTING INDUSTRIES OF AMERICA, INC. | 32203 | PRINTING INDUSTRIES OF AMERICA INC | 2016 | fourth_quarter | PHA | Pharmaceutical Printed Literature | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Labor Relations Board (NLRB),Occupational Safety & Health Administration (OSHA),Securities & Exchange Commission (SEC),SENATE,U.S. Postal Service (USPS) | 80000 | 0 | 0 | 2017-01-09T15:12:25-05:00 | |
| 1910390 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d92ea63f-bf7f-4ccb-a47e-3e5cb2191b3e | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2016 | fourth_quarter | PHA | Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 50000 | 0 | 0 | 2017-01-10T09:24:49-05:00 | |
| 1910398 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 212715e4-c69c-475b-8c30-66fba29ad757 | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2016 | fourth_quarter | PHA | Issues related to anti-epileptic drugs. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2017-01-10T09:26:24-05:00 | |
| 1910412 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e927efd9-fc52-4f06-b2fb-805a7f22395b | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | THE HEMOPHILIA ALLIANCE | 2016 | fourth_quarter | PHA | issues related to the 340B drug discount program | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-10T09:28:25-05:00 | |
| 1910416 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 25c95c83-31df-4ce6-aa4d-47f485029dbe | Q4 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2016 | fourth_quarter | PHA | HR 1600, Patient Access to Treatment Act; HR 2739 Cancer Drug Coverage Parity Act/S. 1566 Cancer Drug Coverage Parity Act | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2017-01-10T09:29:27-05:00 | |
| 1910500 | AMERICAN COLLEGE OF CLINICAL PHARMACY d3ddf61b-b24f-463a-b6b9-aa2098db339b | Q4 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2016 | fourth_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 128875 | 0 | 0 | 2017-01-10T10:50:29-05:00 | |
| 1910889 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 90b6fb65-0a58-4ca3-8b3e-38282c1831eb | Q4 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 58534 | ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 2016 | fourth_quarter | PHA | Any language supporting the expanded use of virtual care/telemedicine, including HR 2799 supporting changes in definitions to expand the use of telemedicine. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 26803 | 0 | 0 | 2017-01-10T16:14:45-05:00 | |
| 1910926 | WAXMAN STRATEGIES b62dacb4-3688-45d4-bacf-798a3ae6ec08 | Q4 | WAXMAN STRATEGIES | 401103693 | 340B HEALTH | 2016 | fourth_quarter | PHA | Laws and regulations affecting the 340B Drug Discount Program | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),White House Office | 18750 | 0 | 0 | 2017-01-10T17:06:08-05:00 | |
| 1911271 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 938d0f85-979e-4c68-8057-01f074438165 | Q4 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 35968 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016 | fourth_quarter | PHA | Implementation of the radiopharmaceutical provisions of The Drug Quality and Security Act as it relates to compounding. | Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE,Veterans Affairs, Dept of (VA) | 60000 | 0 | 0 | 2017-01-11T14:36:00-05:00 | |
| 1911327 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 37e847b6-0844-445b-8078-fe1f2f6cded0 | 4A | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 35968 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016 | fourth_quarter | PHA | Implementation of the radiopharmaceutical provisions of The Drug Quality and Security Act as it relates to compounding. | Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE,Veterans Affairs, Dept of (VA) | 60000 | 0 | 0 | 2017-01-11T15:33:15-05:00 | |
| 1911929 | MR. GALEN RESER 0e1e9ce9-0b65-436c-ac3b-8798943b08f2 | Q4 | MR. GALEN RESER | 401055978 | PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) | 2016 | fourth_quarter | PHA | Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, "Restoring Access to Medication Act of 2015," H.R. 1270, S. 709. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. "Fairness to Pet Owners Act of 2015," S.1200. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-01-12T15:32:08-05:00 | |
| 1911999 | RED+BLUE STRATEGIES 81800efa-03ff-4867-9deb-d20cad0b3ec0 | Q4 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2016 | fourth_quarter | PHA | P.L. 114-255 - 21st Century Cures Act - Issues focused on preventing opioid abuse. H.R. 5327 Continuing Resolution for Appropriations and Military Construction, VA and Related Agencies Act of 2017 and Zika Response and Preparedness Act - issues related to opioid funding and other prescription drug related issues. National Defense Authorization Act of FY 2017 - Work to ensure that the current treatment of mail order for retired and active military personnel and their families remains constant in the pending Authorization bill. The Comprehensive Addiction and Recovery Act(S. 524) - Legislation focused on fighting the opioid epidemic in America, including amendments allowing the use of certain pharmacies and providers to protect Medicare beneficiaries from addiction. The Mental Health Reform Act of 2015 (S. 1945) - Legislation focused on improving treatment for mental health and substance use disorders. Particular focus on formulary policies. Implementation of the health reform law with a focus on policies and regulations related to biosimilars, prescription drug coverage in the Exchanges and related policies. Policies related to Medicare Part C and D with a focus on network design, formularies and access to specialty medications. Issues related to mail order coverage for Medicare, Medicaid, Exchanges, Tricare and other programs. Issues related to the pricing of prescription medications. Rules, regulations, guidance and potential legislation specific to prescription drug pricing, generic utilization, biosimilars medications and specialty pharmacy. Issues related to the treatment of pharmacy benefit managers in federal programs. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Issues related to access and affordability for prescription medications for both government and private sector benefit programs. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-12T16:08:09-05:00 | |
| 1912023 | RED+BLUE STRATEGIES cbfcf8d3-66fe-499f-a7e9-c38651bae151 | Q4 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2016 | fourth_quarter | PHA | P.L. 114-255 - 21st Century Cures Act - Issues focused on preventing opioid abuse. H.R. 5327 Continuing Resolution for Appropriations and Military Construction, VA and Related Agencies Act of 2017 and Zika Response and Preparedness Act - issues related to opioid issues and other prescription drug - related policies. The Comprehensive Addiction and Recovery Act(S. 524) - Legislation focused on fighting the opioid epidemic in America, including amendments allowing the use of certain pharmacies and providers to protect Medicare beneficiaries from addiction. H.R. 2646- The Helping Families in Mental Health Crisis Act - Issues related to prescription drug coverage and benefits. The Mental Health Reform Act of 2015 (S. 1945) - Legislation focused on improving treatment for mental health and substance use disorders. Particular focus on formulary policies. H.R. 244 - The MAC Transparency Act. Clarifying current policies on pricing transparency for prescription drugs that exist under current law and regulatory policies. Implementation of the health reform law with a focus on policies and regulations related to biosimilars, prescription drug coverage in the Exchanges and related policies. Policies related to Medicare Part C and D with a focus on network design, formularies and access to specialty medications. Issues related to Senate Finance Committee activity on advances in chronic care with a focus on medication-based therapies. Work focused on Medicare Part D and related regulations and reports specific to pharmacy networks. Issues related to the implementation of the health care law that impact public and private sector pharmacy benefits. Issues related to pricing and access to prescription drugs including specialty drugs and biosimilars. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-12T16:26:34-05:00 | |
| 1912032 | RED+BLUE STRATEGIES 2735971c-6aae-49c3-981d-5d61c36bbbe8 | Q4 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2016 | fourth_quarter | PHA | P.L. 114-255 - 21st Century Cures Act - Issues focused on preventing opioid abuse. H.R. 5327 Continuing Resolution for Appropriations and Military Construction, VA and Related Agencies Act of 2017 and Zika Response and Preparedness Act - issues related to opioid issues, policies focused on antibiotic resistance and other public health related policies. S. 524 - The Comprehensive Addiction and Recovery Act - supporting efforts to fight opioid abuse in the United States. Work focused on the inclusion of "lock in" programs in the Medicare program to prevent and protect seniors from opioid addiction. S.185 - The Promise for Antibiotics and Therapeutics for Health (PATH) Act - Focused on ensuring that the Food and Drug Administration has the necessary to tools to ensure that medically needed antibiotics are made available to the public. S. 2153 - Provider Payment Sunshine Act - policies supporting the inclusion of all prescribers to the Open Payments program. H.R. 5054 - Agriculture Appropriations Bill for FY 2017 - Issues related to FDA treatment of antibiotics and compounding of certain pharmaceuticals. Legislative and regulatory issues surrounding unique device identifiers (UDI) being addressed by CMS, FDA and ONC. Advancing provisions to highlight Antibiotic Innovation and combating prescription drug abuse in the President's FY 2017 budget. Supporting policies to maintain the integrity of laws regarding compounding of certain medications. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid. | HOUSE OF REPRESENTATIVES,SENATE | 25000 | 0 | 0 | 2017-01-12T16:33:01-05:00 | |
| 1912445 | ACADEMY OF MANAGED CARE PHARMACY d80eef78-b052-4f2f-8077-6a7b069e5f45 | Q4 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2016 | fourth_quarter | PHA | Medicare Part D issues concerning managed care pharmacy, comments to FDA on BsUFA II reauthorization citing a need for biosimilars education and post market surveillance, comments in support of 21st Century Cures Act to support Section 3037 - Health care economic information, comments to CMS regarding implementation of CARA - P.L. 114-198, and comments to CMS on Medicare Part D MTM program. Meetings with Congressional office staff to seek support for amending current law consistent with HIPAA to allow health plans to access patient addiction records. Meeting with OMB to discuss impact of the SAMSHA pending final rule on confidentiality of substance abuse records (42 CFR Part 2). | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 158000 | 0 | 0 | 2017-01-13T11:16:14-05:00 | |
| 1912543 | OREGON HEALTH & SCIENCE UNIVERSITY 754615d8-06ba-46ae-8912-3d84b426a769 | Q4 | OREGON HEALTH & SCIENCE UNIVERSITY | 30291 | OREGON HEALTH & SCIENCE UNIVERSITY | 2016 | fourth_quarter | PHA | 340b Drug Discount Program for safety net hospitals and Health Resources and Services Administration proposed omnibus guidance. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2017-01-13T11:54:18-05:00 | |
| 1912588 | ROCK & ASSOCIATES 44d59367-4b9b-4f6d-929b-ee32ef81613e | Q4 | ROCK & ASSOCIATES | 33545 | BRAIDWOOD MANAGEMENT, INC. | 2016 | fourth_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2017-01-13T12:21:44-05:00 | |
| 1912596 | ROCK & ASSOCIATES 6eaaa547-b023-40ae-b890-993243d13388 | Q4 | ROCK & ASSOCIATES | 33545 | DIAMONDBACK DRUGS | 2016 | fourth_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2017-01-13T12:24:37-05:00 | |
| 1912601 | ROCK & ASSOCIATES 4ea9fd31-46e0-49e0-a2ce-672b18aaaba7 | Q4 | ROCK & ASSOCIATES | 33545 | VETERINARY PHARMACIES OF AMERICA, INC. | 2016 | fourth_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2017-01-13T12:25:28-05:00 | |
| 1912604 | ROCK & ASSOCIATES 74aed679-1ccb-4a1a-b996-498f1c829368 | Q4 | ROCK & ASSOCIATES | 33545 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2016 | fourth_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2017-01-13T12:26:23-05:00 | |
| 1912611 | ROCK & ASSOCIATES 1cfb61dc-a8c4-47c5-8a88-336e262bd254 | Q4 | ROCK & ASSOCIATES | 33545 | WOMEN'S INTERNATIONAL PHARMACY | 2016 | fourth_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2017-01-13T12:27:24-05:00 | |
| 1912618 | ROCK & ASSOCIATES 5313ef39-8662-4915-8fb6-cbc92fce57c5 | Q4 | ROCK & ASSOCIATES | 33545 | WELLNESS PHARMACY | 2016 | fourth_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2017-01-13T12:28:07-05:00 | |
| 1912735 | HOLLAND & KNIGHT LLP 41af72f9-658f-4458-9c86-5e7daea700a0 | Q4 | HOLLAND & KNIGHT LLP | 18466 | PROTECTING ACCESS TO PAIN RELIEF COALITION | 2016 | fourth_quarter | PHA | Advocating for policy to ensure patient access to pain relief. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-13T14:08:58-05:00 | |
| 1912874 | HOLLAND & KNIGHT LLP 698a1945-670d-4d1e-a707-64bc55b97cd5 | Q4 | HOLLAND & KNIGHT LLP | 18466 | THE BIOSIMILARS FORUM | 2016 | fourth_quarter | PHA | Medicare reimbursement issues, FDA regulation of biosimilars. | HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2017-01-13T15:03:57-05:00 | |
| 1912910 | AMERICAN AMBULANCE ASSOCIATION 60a161b0-e7ab-4d2c-8be3-42483cfec00c | Q4 | AMERICAN AMBULANCE ASSOCIATION | 56018 | AMERICAN AMBULANCE ASSOCIATION | 2016 | fourth_quarter | PHA | Lobbied in support of the Protecting Patient Access to Emergency Medications Act (H.R. 4365, S. 2932) to ensure the continuity of standing orders for the administration of certain controlled substances by paramedics and EMTs to patients. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 260000 | 0 | 0 | 2017-01-13T15:23:16-05:00 | |
| 1913175 | RED+BLUE STRATEGIES 45e34e8e-e10d-4273-bf77-136b0ad0e47d | Q4 | RED+BLUE STRATEGIES | 400693064 | BLUE CROSS BLUE SHIELD OF MASSACHUSETTS | 2016 | fourth_quarter | PHA | PL - 114- 255 - 21st Century Cures Act. Provisions to include help fight against opioid abuse. H.R. 5327 - Continuing Appropriations and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs. S. 524 - the Comprehensive Addition and Recovery Act- issues related to ensuring best prescribing practices for opioids in the country and solutions developed by BCBSMA to combat abuse. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-13T17:14:48-05:00 | |
| 1913210 | RED+BLUE STRATEGIES 1c98b72e-db1d-4658-8df0-b1209f1110e1 | Q4 | RED+BLUE STRATEGIES | 400693064 | COHERUS BIOSCIENCES | 2016 | fourth_quarter | PHA | H.R. 5054 - Agriculture Appropriations Bill for FY 2017- issues related to finding the Food and Drug Administration's Office of Biosimilars. Education and advocacy related to what elements are necessary to ensure a hospitable environment to grow the new Biosimilars market in the United States and the positive impact these medications will have on drug cost and access. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-13T17:27:50-05:00 | |
| 1913308 | THE INGRAM GROUP LLC fad97564-4a35-4e4d-8b33-a534ed83b9c1 | Q4 | THE INGRAM GROUP LLC | 400577737 | ELI LILLY AND COMPANY | 2016 | fourth_quarter | PHA | S.2030, Advancing Targeted Therapies for Rare Diseases Act of 2015. H.R.34, 21st Century Cures Act (P.L.114-255). H.R.2028, Further Continuing and Security Assistance Appropriations Act, 2017 (P.L.114-254). General issues related to the biopharmaceutical and pharmaceutical industries. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2017-01-14T11:44:54-05:00 | |
| 1913638 | BLUE CROSS AND BLUE SHIELD ASSOCIATION 2d09b033-9a99-44f2-9fd0-8c11cbfd801c | Q4 | BLUE CROSS AND BLUE SHIELD ASSOCIATION | 6358 | BLUE CROSS AND BLUE SHIELD ASSOCIATION | 2016 | fourth_quarter | PHA | Opioid Abuse; Opioid Education; Prescription Drugs HR 953 Introduced February 12, 2015 by James Sensenbrenner, Jr. (R-WI) Comprehensive Addiction and Recovery Act of 2015 Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related death in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled in the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states. New legislation aims to tackle this epidemic. The Comprehensive Addiction and Recovery Act, S. 524 and H.R. 953, was introduced by Sen. Sheldon Whitehouse (D-RI) and Rep. Jim Sensenbrenner (R-WI5) and will receive a hearing on Thursday from the Senate Judiciary Committee. HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement -Act of 2015 Introduced June 17, 2915 by Susan Brooks (R-IN) This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication. HR 4499 Introduced February 9, 2016 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend title XVIII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 2160000 | 0 | 0 | 2017-01-15T21:24:38-05:00 | |
| 1913923 | THORSEN FRENCH ADVOCACY LLC b54814c2-02ec-4ab7-a40d-20072bc3d846 | Q4 | THORSEN FRENCH ADVOCACY LLC | 400599826 | CARDINAL HEALTH, INC. | 2016 | fourth_quarter | PHA | Issues related to prescription drug abuse. Issues related to pharmaceutical market value. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-16T13:03:02-05:00 | |
| 1913927 | INDEPENDENT PHARMACY COOPERATIVE ab0d8613-cfe8-4fa0-9b11-7bbd7a3c25ca | Q4 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2016 | fourth_quarter | PHA | H.R. 592/S.314 Pharmacy and Medically Underserved Areas Enhancement Act. IPC is supportive of pharmacists being recognized as providers under Medicare Part B for these areas. H.R. 793 Ensuring Seniors Access to Local Pharmacies Act. IPC is support of local pharmacies being able to participate in Medicare Part D in these underserved areas. S.524 Comprehensive Addiction and Recovery Act of 2016. IPC was against law as written. Actual Acquisition Cost (AAC) adoption with state Medicaid programs. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-16T13:04:24-05:00 | |
| 1913950 | THORSEN FRENCH ADVOCACY LLC d4e597c4-85ed-4463-9a13-03517af386b4 | Q4 | THORSEN FRENCH ADVOCACY LLC | 400599826 | HEALTHCARE DISTRIBUTION ALLIANCE | 2016 | fourth_quarter | PHA | General issues related to prescription drug abuse. Issues related to pharmaceutical market value. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-16T13:22:18-05:00 | |
| 1913965 | THORSEN FRENCH ADVOCACY LLC 429aa3e6-3406-4d8c-9fba-1f9d01b03064 | Q4 | THORSEN FRENCH ADVOCACY LLC | 400599826 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2016 | fourth_quarter | PHA | Issues related to pharmaceutical market value. Issues related to prescription drug abuse. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-16T13:29:02-05:00 | |
| 1913972 | THORN RUN PARTNERS ee2cfbb6-3d0c-4b9d-a609-71a5e514511e | Q4 | THORN RUN PARTNERS | 400534596 | EXPRESS SCRIPTS, INC. | 2016 | fourth_quarter | PHA | H.R.244, MAC Transparency Act; pharmacy benefits manager standards under the Medicare prescription drug program to further transparency of payment methodologies to pharmacies. P.L.114-328, National Defense Authorization Act for Fiscal Year 2017; provision authorizing a pilot program in TRICARE that would establish Department of Defense (DoD) acquisition cost parity for prescription drugs obtained at community pharmacies. Drug reimbursement and general pharmacy related issues. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-16T13:32:07-05:00 | |
| 1915353 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS d7cfdfa6-cdbe-444f-b37c-97ba9dd4159f | Q4 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2016 | fourth_quarter | PHA | Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Contact concerning the Drug Quality and Security Act, all titles. Communication with the FDA on Generic Drug User Fee Act, Prescription Drug User Fee Act, Biosimilar User Fee Act, and electronic drug information. Expressed support for S. 524, Comprehensive Addiction and Recovery Act of 2016. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE | 230000 | 0 | 0 | 2017-01-17T13:23:23-05:00 | |
| 1915457 | KOUNTOUPES DENHAM CARR & REID, LLC cf7669d4-f9fe-4191-8be3-af429df08f75 | Q4 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2016 | fourth_quarter | PHA | General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. Issues related to the over the counter drug monograph process. Issues related to the disposal of unused over the counter drugs. Issues related to the FDA regulatory process by which prescription medicines are switched to Over the Counter. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-17T13:46:24-05:00 | |
| 1915474 | MEHLMAN CONSULTING, INC. a68fa7df-990e-49b9-83a3-1f2f7c82a7db | Q4 | MEHLMAN CONSULTING, INC. | 284950 | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | 2016 | fourth_quarter | PHA | Issues related to transparency and competition in the prescription drug market. S.3056, Creating and Restoring Equal Access to Equivalent Samples Act of 2016 (CREATES). S. 3335, Fair Accountability and Innovative Research Drug Pricing Act of 2016 (FAIR). Food and Drug Administration Appropriations Act. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-01-17T13:54:23-05:00 | |
| 1915551 | PARRY, ROMANI, DECONCINI & SYMMS 30b8e8b1-790c-4161-b6e9-e6fb5a18aa33 | Q4 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | ROCK & ASSOCIATES | 2016 | fourth_quarter | PHA | Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act. | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2017-01-17T14:17:52-05:00 | |
| 1915914 | PRIME THERAPEUTICS 12432f87-3c38-4bd8-bac4-0e97f0cbe9d1 | Q4 | PRIME THERAPEUTICS | 400339576 | PRIME THERAPEUTICS | 2016 | fourth_quarter | PHA | H.R.4784: Lower Drug Costs Through Competition Act, support increasing generic availability. S.2680: A bill to amend the Public Health Service Act to provide comprehensive mental health reform, and for other purposes. S.2615: the Increasing Competition in Pharmaceuticals Act. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-17T16:00:42-05:00 | |
| 1915930 | RUBICON ADVISORS, LLC 77918752-a906-4ca9-bba2-ea45af04a2d4 | Q4 | RUBICON ADVISORS, LLC | 315091 | TEVA PHARMACEUTICALS USA | 2016 | fourth_quarter | PHA | 21st Century Cures Act | HOUSE OF REPRESENTATIVES,SENATE | 105000 | 0 | 0 | 2017-01-17T16:06:33-05:00 | |
| 1915935 | RUBICON ADVISORS, LLC 9f08491b-61a1-410a-8597-1a8f76db91a1 | Q4 | RUBICON ADVISORS, LLC | 315091 | DYNAVAX TECHNOLOGIES | 2016 | fourth_quarter | PHA | Pharmaceuticals | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2017-01-17T16:07:45-05:00 | |
| 1915940 | RUBICON ADVISORS, LLC c04249b4-8b94-48b9-9f64-02569a0a1b76 | Q4 | RUBICON ADVISORS, LLC | 315091 | ALLIANCE TO PREVENT THE ABUSE OF MEDICINES | 2016 | fourth_quarter | PHA | Prescription drug abuse policy | HOUSE OF REPRESENTATIVES,SENATE | 82500 | 0 | 0 | 2017-01-17T16:09:35-05:00 | |
| 1915941 | RUBICON ADVISORS, LLC 45ed3506-95d7-45f2-a5f5-f11ec78e9d7e | Q4 | RUBICON ADVISORS, LLC | 315091 | COLLEGE OF AMERICAN PATHOLOGISTS | 2016 | fourth_quarter | PHA | Physician Payment Rates, Electronic Health Records Incentives program | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-01-17T16:11:00-05:00 | |
| 1915942 | RUBICON ADVISORS, LLC 88709b29-7334-4f8b-b646-c15d84f8d47b | Q4 | RUBICON ADVISORS, LLC | 315091 | DR. REDDY'S LABORATORIES, LTD | 2016 | fourth_quarter | PHA | Food and Drug Administration, Generic Drug User Fees, NHI, DEA | Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 45000 | 0 | 0 | 2017-01-17T16:12:32-05:00 | |
| 1916379 | FTI GOVERNMENT AFFAIRS 5518691a-7e41-41ac-940f-fff6a0f0682c | Q4 | FTI GOVERNMENT AFFAIRS | 401054971 | PROFESSIONAL COMPOUNDING CENTERS OF AMERICA | 2016 | fourth_quarter | PHA | Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law) ((USP/NF Monograph)). | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-17T19:25:18-05:00 | |
| 1916572 | CROSSROADS STRATEGIES, LLC 31297d39-56ee-4f1f-951c-3ab1469e4ab3 | Q4 | CROSSROADS STRATEGIES, LLC | 400531586 | EMD SERONO, INC. | 2016 | fourth_quarter | PHA | General pharmaceutical coverage and reimbursement issues. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-17T23:13:32-05:00 | |
| 1916585 | SAFEWAY INC. 05fb4d81-4249-48c2-af16-a1324a88862c | Q4 | SAFEWAY INC. | 300173 | SAFEWAY | 2016 | fourth_quarter | PHA | H.R. 592/S. 314, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions. H.R. 4909, FY 2017 National Defense Authorization Act, provisions related to TRICARE and pharmacy access. H.R. 953/S. 524, Comprehensive Addition and Recovery Act, provisions related to state prescription drug monitoring programs. H.R. 793/S. 1190, Ensuring Seniors Access to Local Pharmacies Act of 2015, all provisions. H.R. 3250, DXM Abuse Prevention Act, provisions related to retail pharmacy. | HOUSE OF REPRESENTATIVES,SENATE | 220000 | 0 | 0 | 2017-01-17T23:46:08-05:00 | |
| 1916673 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION c28f2f31-f87f-4a40-abb8-e7abaceb9e42 | Q4 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2016 | fourth_quarter | PHA | H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees; | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),SENATE | 245000 | 0 | 0 | 2017-01-18T08:03:41-05:00 | |
| 1916914 | GREATER NEW YORK HOSPITAL ASSOCIATION 32dcd141-36a5-4cc3-bfed-2f49bc644196 | Q4 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2016 | fourth_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases and support draft reform legislation; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment, oppose use of savings from home infusion payment reform for purposes other than creating a Medicare home infusion benefit; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (H.R.592/S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524-0002 - comments, Administration and Capitol Hill meetings on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments and Capitol Hill meetings on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose; 21st Century Cures Act (H.R.6, now P.L.114-255) - … | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 400000 | 0 | 0 | 2017-01-18T10:00:04-05:00 | |
| 1917348 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES 64a55a73-bb33-4aff-b5c8-49a437f01520 | Q4 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2016 | fourth_quarter | PHA | H.R.5194 - 114th Congress (2015-2016)Safe Drug Disposal Tax Credit Act of 2016 H.R. 2841 the FAST Generics Act of 2015. S.3056: CREATES Act of 2016. | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 380000 | 0 | 0 | 2017-01-18T11:24:37-05:00 | |
| 1917365 | BLUECROSS BLUESHIELD OF TENNESSEE acc6b66f-e9bd-4a12-b8b7-e646a6fe37b7 | Q4 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2016 | fourth_quarter | PHA | Precision Medicine Act (S2713); General Pharmacy Issues (HR6/2713); opioid abuse (S524, HR953, HR2805, HR4499); specialty drug pricing | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-18T11:29:16-05:00 | |
| 1917421 | THE D MAJOR GROUP cf47dc22-9d35-4d1d-9b03-2a0d1a56f48d | Q4 | THE D MAJOR GROUP | 401103162 | CVS CAREMARK | 2016 | fourth_quarter | PHA | Issues related to pharmacy delivery including S. 2615, The Increasing Competition in Pharmaceuticals Act; H.R. 34, The 21st Century Cures Act; and H.R. 244, The MAC Transparency Act. | HOUSE OF REPRESENTATIVES,SENATE | 34500 | 0 | 0 | 2017-01-18T11:34:40-05:00 | |
| 1917689 | WALTER CONSULTING c4c15172-b7d0-40fa-ac0e-b38bcde924a3 | 4T | WALTER CONSULTING | 301697 | AMERISOURCEBERGEN CORPORATION | 2016 | fourth_quarter | PHA | H.R. 471, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483, The Regulatory Transparency, Patient Access and Effective Drug Enforcement Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2017-01-18T12:46:00-05:00 | |
| 1917759 | KOUNTOUPES DENHAM CARR & REID, LLC 7a29ea93-a4ac-4c3a-a7e6-ea128b46ea55 | Q4 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | CVS HEALTH | 2016 | fourth_quarter | PHA | General education about the pharmacy benefit manager/pharmacy industry. Issues related to H.R. 6, The 21st Century Cures Act. Affordability and pricing of pharmaceuticals. S.3455 the CREATES Act and H.R. 2841 the FAST Generics Act. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-18T12:56:07-05:00 | |
| 1917787 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 81050dbf-876a-452c-8051-83c1b6244ae7 | Q4 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2016 | fourth_quarter | PHA | Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Extended Producer Responsibility/Pharmaceutical Stewardship (Drug Take-Back) H.R. 4931 - Pharmaceutical Stewardship Act of 2016. Requires the Drug Enforcement Administration to establish and implement a national pharmaceutical stewardship program to collect and dispose of prescription medications; all sections. H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 (COARA). Amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Attorney General to make grants to assist State and local governments in addressing the national epidemic of opioid abuse, and for other purposes (all sections). S. 524 - Comprehensive Addiction and Recovery Act of 2016 (CARA; became P.L. 114-198 on 7/22/2016). Authorizes the Attorney General and Secretary of Health and Human Services to award grants to address the national epidemics of prescription opioid abuse and heroin use, and to provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes (Section 201 - expands eligible uses of grant funds to include drug take-back efforts; Section 203 requires coordination among multiple government agencies to develop a prescription drug take-back program). Oral Contraceptives H.R. 5138 - Over-the-Counter Contraceptives Act of 2016. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. S. 1438 - Allowing Greater Access to Safe and Effective Contraception Act. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-… | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 370000 | 0 | 0 | 2017-01-18T13:00:16-05:00 | |
| 1917850 | CHAMBER HILL STRATEGIES 676a23d0-5f30-4f91-b1ad-1edd18fdee0e | Q4 | CHAMBER HILL STRATEGIES | 400645947 | AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL) | 2016 | fourth_quarter | PHA | Implementation issues related to P.L. 113-54, the Drug Quality and Security Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-18T13:18:10-05:00 | |
| 1917866 | JOHNS HOPKINS UNIVERSITY 77e16c14-dd5a-4c17-911a-40eee1cb6de0 | Q4 | JOHNS HOPKINS UNIVERSITY | 20664 | JOHNS HOPKINS UNIVERSITY | 2016 | fourth_quarter | PHA | Pharmaceutical drug prices | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,White House Office | 90000 | 0 | 0 | 2017-01-18T13:23:10-05:00 | |
| 1918334 | HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC dc0d01de-c2d1-4b91-9191-b352513c2571 | 4T | HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC | 17966 | ELI LILLY AND COMPANY | 2016 | fourth_quarter | PHA | Policy issues relating to prescription drug prices. | 30000 | 0 | 1 | 2017-01-18T14:38:09-05:00 | ||
| 1918584 | POWERS PYLES SUTTER & VERVILLE, P.C. ee282b4f-7ff5-4da6-8565-57ba6a2fa3b7 | Q4 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | 340B HEALTH | 2016 | fourth_quarter | PHA | Section 340B of the Public Health Services Act, Section 1927 of the Social Security Act and issues related to (1) administration and Congressional oversight of the 340B Drug Discount Program, (2) implementation of 340B-related provisions in the Patient Protection and Affordable Care Act of 2010, and (3) funding of the Health Resources and Services Administration (HRSA)under the Labor Health & Human Services & Education appropriations bills. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2017-01-18T15:10:54-05:00 | |
| 1918655 | THE PROCTER AND GAMBLE COMPANY 8c948a71-7f26-4be2-9efd-83994728de4c | Q4 | THE PROCTER AND GAMBLE COMPANY | 32225 | THE PROCTER AND GAMBLE COMPANY | 2016 | fourth_quarter | PHA | - Dextromethorphan Abuse Reduction - HR 3250, DXM Abuse Prevention Act of 2015 - Regulation of OTC drugs, devices and cosmetics - HR 4075, Cosmetic Modernization Amendments of 2015 - S.1014, The Personal Care Products Safety Act | Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR) | 779741 | 0 | 0 | 2017-01-18T15:23:44-05:00 | |
| 1918683 | KOUNTOUPES DENHAM CARR & REID, LLC 1339f8fc-be05-4e23-b069-05657407563a | Q4 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) | 2016 | fourth_quarter | PHA | Policy matters related to generic pharmaceuticals and biosimilars including naming, labeling, access and interchangeability and changes to the Risk Evaluation and Mitigation Strategies (REMS) program, H.R.2841, FAST Generics Act of 2015 and S.3056, The CREATES Act, access to samples for generic testing, including S.3455, the Pharmaceutical Supply and Value Enhancement (SAVE) Act. The 21st Century Cures Act included in H. R. 2028, Further Continuing and Security Assistance Appropriations Act for Fiscal Year 2017. Affordability and pricing of pharmaceuticals. Issues related to drug takeback and opioid addiction. H. R. 4931, The Pharmaceutical Stewardship Act of 2016 and S.2977, The Budgeting for Opioid Addiction Treatment Act. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 60000 | 0 | 0 | 2017-01-18T15:28:16-05:00 | |
| 1918702 | AVANIR PHARMACEUTICALS aed0ca0a-14fd-45e5-b1cf-7347120198f5 | Q4 | AVANIR PHARMACEUTICALS | 401103474 | AVANIR PHARMACEUTICALS | 2016 | fourth_quarter | PHA | Drug pricing | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-01-18T15:31:54-05:00 | |
| 1918892 | UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY b9cacca9-7b79-418a-addc-0a2320d9449f | Q4 | UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY | 401097063 | UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY | 2016 | fourth_quarter | PHA | 340B Program Mega Guidance | HOUSE OF REPRESENTATIVES,SENATE | 8124 | 0 | 0 | 2017-01-18T16:04:27-05:00 | |
| 1919205 | TARPLIN, DOWNS & YOUNG, LLC 098197d8-4607-40e3-a5ab-7a431b6fca7f | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | ASTRAZENECA | 2016 | fourth_quarter | PHA | PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 3204 - The Drug Quality and Security Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans H.R. 34 - 21st Century Cures Act ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements, user fee sequester relief, Innovation | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2017-01-18T16:46:29-05:00 | |
| 1919446 | TARPLIN, DOWNS & YOUNG, LLC 7300d101-a72c-4156-9525-f4f6a5d96b5b | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2016 | fourth_quarter | PHA | PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 3204 - The Drug Quality and Security Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans H.R. 34 - 21st Century Cures Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee sequester, Innovation | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2017-01-18T17:14:19-05:00 | |
| 1919493 | TARPLIN, DOWNS & YOUNG, LLC 0fda8461-744e-48bd-b169-f6ce694c2108 | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2016 | fourth_quarter | PHA | Importation of prescription drugs (S. 122, H.R. 2228) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs (S. 480, H.R. 1725) Prescription Drug Abuse - General issues related to Rx drug abuse (H.R. 471, S. 483, S. 524, H.R. 953, H.R. 4641) 21st Century Cures (H.R. 6, H.R. 34) | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-01-18T17:22:19-05:00 | |
| 1919523 | FOLEY HOAG LLP cb9a4ffc-d939-40f0-b9c9-f7c9bfd9403f | Q4 | FOLEY HOAG LLP | 79610 | GILEAD SCIENCES INC | 2016 | fourth_quarter | PHA | Coverage of pharmaceuticals, cost-sharing and other access issues; H.R. 6 - 21st Century Cures Act; Implementation of Public Law No: 111-148, the Patient Protection and Affordable Care Act; issues related to coverage and reimbursement of pharmaceuticals; issues related to Medicare, Medicaid and Affordable Care Act implementation; FDA issues and 340B. S. 3056: CREATES Act of 2016. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-18T17:28:51-05:00 | |
| 1919531 | TEVA PHARMACEUTICALS USA, INC. 7eb7825a-b4b9-43d0-909f-1b1cdfcc1e42 | Q4 | TEVA PHARMACEUTICALS USA, INC. | 76695 | TEVA PHARMACEUTICALS USA INC | 2016 | fourth_quarter | PHA | Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; drug pricing proposals and issues; and biosimilars reimbursement. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) | 930000 | 0 | 0 | 2017-01-18T17:29:55-05:00 | |
| 1919537 | COVINGTON & BURLING LLP 9240641a-78d9-4c4f-b029-3681cf3508b1 | Q4 | COVINGTON & BURLING LLP | 11195 | CELGENE CORPORATION | 2016 | fourth_quarter | PHA | Opposing the CREATES Act, S. 3056 | HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2017-01-18T17:32:36-05:00 | |
| 1919562 | TARPLIN, DOWNS & YOUNG, LLC 23a51528-f10d-4548-9402-1ada52295bba | Q4 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | PHRMA | 2016 | fourth_quarter | PHA | PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 3204 - The Drug Quality and Security Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans H.R. 34 - 21st Century Cures Act ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies, user fee sequester, innovation | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-01-18T17:36:32-05:00 | |
| 1919632 | FTI GOVERNMENT AFFAIRS 1e473534-1cac-494d-8398-ba7c52b11c88 | Q4 | FTI GOVERNMENT AFFAIRS | 401054971 | PERRIGO, INC. | 2016 | fourth_quarter | PHA | Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, "Restoring Access to Medication Act of 2015," H.R. 1270, S. 709. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. "Fairness to Pet Owners Act of 2015," S.1200. | HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2017-01-18T17:48:25-05:00 | |
| 1919751 | TROUTMAN STATEGIES 60c28d1f-d8e2-4351-842b-e7b7c650087f | Q4 | TROUTMAN STATEGIES | 81511 | DERMATRAN HEALTH SOLUTIONS LLC | 2016 | fourth_quarter | PHA | Monitor and lobby legislation and regulation relating to compounding pharmacies. | Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 40000 | 0 | 0 | 2017-01-18T18:16:21-05:00 | |
| 1920592 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 58044adc-7e2a-40ae-975f-8e62030a06ca | Q4 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2016 | fourth_quarter | PHA | Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs (S. 480, H.R. 1725); Prescription Drug Abuse - General issues related to Rx drug abuse, (H.R. 471, S. 483, S. 524, H.R. 953, H.R. 4641); 21st Century Cures (H.R. 6, H.R. 34); Importation of Prescription Drugs (S. 122, H.R. 2228; Issues related to pharmaceutical market value | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 268000 | 0 | 0 | 2017-01-19T09:30:32-05:00 | |
| 1920842 | MASSACHUSETTS MEDICAL SOCIETY ffb95c22-b8b8-4a63-a663-4aa3d0ae204f | Q4 | MASSACHUSETTS MEDICAL SOCIETY | 23975 | MASSACHUSETTS MEDICAL SOCIETY | 2016 | fourth_quarter | PHA | Prescription Drug Pricing - no specific bill Direct to Consumer Advertising - no specific bill Negotiating Prescription Drug Prices for Medicare and Medicaid - no specific bill | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 50000 | 0 | 0 | 2017-01-19T10:02:25-05:00 | |
| 1920866 | NATIONAL HOME INFUSION ASSOCIATION 162ad177-ea33-4f4c-bc02-38b186026b98 | Q4 | NATIONAL HOME INFUSION ASSOCIATION | 40047365 | NATIONAL HOME INFUSION ASSOCIATION | 2016 | fourth_quarter | PHA | Compounding pharmacy regulation - worked to ensure the Drug Quality and Security Act (Pub.L. 113-54) is being properly implemented, specifically the draft memorandum of understanding for 503A pharmacies and FDA inspections of 503A pharmacies. Lobbied for the inclusion of Department of Agriculture/FDA appropriations language regarding inspection authority and scope of the draft memorandum of understanding. Lobbied on proper inspections of 503A pharmacies. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 125000 | 0 | 0 | 2017-01-19T10:04:31-05:00 | |
| 1920984 | FORBES-TATE d7679e46-e9ae-4755-bd6f-bb34aeb1b346 | Q4 | FORBES-TATE | 400976792 | PHRMA | 2016 | fourth_quarter | PHA | Issues related to Medicare Part D; Issues related to the drug industry; Issues related to comparative effectiveness; Issues related to follow-on biologics; Issues related to the Independent Payment Advisory Board; Issues related to patent reform; Issues related to ASP+6 and Part B rule; Issues related to PCORI; Issues related to pharmaceutical drug safety track and trace program legislation; Issues related to low income subsidies; Issues related to the Vice President's National Cancer Moonshot Initiative. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2017-01-19T10:16:19-05:00 | |
| 1921134 | AKIN GUMP STRAUSS HAUER & FELD 0123e625-7674-4de9-bb7a-62a34b62e51f | Q4 | AKIN GUMP STRAUSS HAUER & FELD | 682 | PHARMEDIUM SERVICES, LLC | 2016 | fourth_quarter | PHA | Drug Quality and Security Act, Pub. L. 113-54; FDA regulatory implementation of Section 503B of the Food, Drug and Cosmetic Act; FDA Pharmacy Compounding Advisory Committee; House & Senate Agriculture, FDA & Related Agency Appropriations bills | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-01-19T10:33:15-05:00 | |
| 1921457 | QGA PUBLIC AFFAIRS (FORMERLY QUINN GILLESPIE & ASSOCIATES) b28f424b-69c1-40f3-879c-16a9fa17117a | Q4 | QGA PUBLIC AFFAIRS (FORMERLY QUINN GILLESPIE & ASSOCIATES) | 54197 | NEKTAR THERAPEUTICS | 2016 | fourth_quarter | PHA | FDA oversight of certain pain-reliever products | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-19T11:04:25-05:00 | |
| 1921483 | EVERGREEN ASSOCIATES, LTD. dcfbbdd9-6878-43a6-bbc3-d18c823a97d6 | Q4 | EVERGREEN ASSOCIATES, LTD. | 13984 | PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION | 2016 | fourth_quarter | PHA | - Docket ID: FDA-2007-N-0363: Electronic Distribution of Content of Labeling for Human Prescription Drug and Biological Product - H.R. 5054/S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017: Title VII - General Provisions; Sec. 734 - (Draft) Cody Miller Patient Medication Information Act - H.R. 2028: Further Continuing and Security Assistance Appropriations Act, 2017: Division A - Further Continuing Appropriations Act, 2017, Sec. 101 | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2017-01-19T11:06:24-05:00 | |
| 1921661 | FOLEY & LARDNER LLP ac60a372-51fa-4eba-a3d0-7047c3f3f378 | Q4 | FOLEY & LARDNER LLP | 15042 | ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY | 2016 | fourth_quarter | PHA | FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market; Issues relating to the Comprehensive Addiction and Recovery Act of 2016. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2017-01-19T11:21:33-05:00 | |
| 1921771 | FOLEY & LARDNER LLP a3134804-984b-404c-aad1-0f99f78b5bc0 | Q4 | FOLEY & LARDNER LLP | 15042 | PAR PHARMACEUTICAL | 2016 | fourth_quarter | PHA | FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market; Issues relating to the Comprehensive Addiction and Recovery Act of 2016. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2017-01-19T11:32:40-05:00 | ||
| 1921934 | MCDERMOTT+ LLC da196219-e312-4006-a6de-80e929bb4aaa | Q4 | MCDERMOTT+ LLC | 401103287 | ALLIANCE FOR RURAL HOSPITAL ACCESS | 2016 | fourth_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-19T11:47:36-05:00 | |
| 1922562 | BOCKORNY GROUP, INC. 7984370d-58d7-41db-9fb9-dcd7d6b85772 | Q4 | BOCKORNY GROUP, INC. | 289773 | CVS HEALTH INC | 2016 | fourth_quarter | PHA | Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety. Issues related to reimbursement for Home Infusion | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-01-19T12:51:11-05:00 | |
| 1922858 | MERCURY PUBLIC AFFAIRS, LLC 968d1b23-cb18-4f46-963d-a3ebd6d05d8f | Q4 | MERCURY PUBLIC AFFAIRS, LLC | 70175 | KALISPELL REGIONAL HEALTHCARE | 2016 | fourth_quarter | PHA | Veteran pharmacy issues and polices | Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 30000 | 0 | 0 | 2017-01-19T13:21:23-05:00 | |
| 1923295 | PD FRAZER CONSULTING, INC. bdf300f3-63d9-40c4-9f58-3771480b2c60 | Q4 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2016 | fourth_quarter | PHA | Of interest are S.122 Safe and Affordable Drugs From Canada Act of 2015 and H.R.2228 Safe and Affordable Drugs From Canada Act of 2015. Monitor the development of these proposed bills about the importation of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2017-01-19T14:11:42-05:00 | |
| 1923440 | 340B HEALTH 79d52073-6145-45e0-807d-bd4b40733df3 | Q4 | 340B HEALTH | 316434 | 340B HEALTH | 2016 | fourth_quarter | PHA | The 340B Drug Pricing program, Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance,FY17 Labor Health and Human Services Appropriations,Delaware Medicaid State Plan Amendment, CMS Medicaid and CHIP Managed Care Final Rule, CMS Covered Outpatient Drug Final Regulation, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 179250 | 0 | 0 | 2017-01-19T14:23:36-05:00 | |
| 1923510 | THE CONAFAY GROUP, LLC 565df624-40b4-4742-9df3-23ca3dfe18bd | Q4 | THE CONAFAY GROUP, LLC | 401004840 | TROIA THERAPEUTICS INC. | 2016 | fourth_quarter | PHA | FDA Regulatory Process. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2017-01-19T14:37:01-05:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);